Most diseases are still poorly understood at a biological level. Despite decades of research, the causal mechanisms driving many conditions remain unclear, limiting our ability to identify the right targets, design the right interventions and bring the right medicines to patients.
The AI Accelerator exists to change that. Based in London and sitting within Computational Innovation (@computationalinnovation), a global organisation spanning computational biology, human genetics, data excellence and AI, the Accelerator’s mission is to build production-quality AI capabilities that deepen our understanding of disease biology and increase probability of success.
We do this by applying neural-based methods across the biomedical data landscape to integrate heterogeneous, multimodal data sources, infer biological relationships and embed causal thinking into what we build. The goal is not just to predict but to explain and understand why disease occurs.
It could be electronic health records and medical imaging to support patient segmentation. It could be ‘omics data to identify novel therapeutic targets. It could be predicting transcriptional change for a given disease-causing variant. It could be simulating the effect of modulating a target of interest.
A core component of the AI Accelerator is AI Enablement, that provides the support framework to make our ambitions a technical reality. It could be provisioning integrated, multimodal biomedical data for model training and inference. It could be managing the lifecycle of models provided by AI Systems. It could be working with IT to ensure the right infrastructure and tooling are in place. AI Enablement ensures that the model builders can focus on the technology and that Computational Innovation’s downstream users can leverage accelerator capabilities for real portfolio impact.
We are looking for a Senior MLOps Engineer to join AI Enablement and play a central role in ensuring that the AI Accelerator’s models move from development to production reliably and keep performing. This is a hands-on operational role with real stakes. The models you deploy and manage will be used to make decisions about which indications to pursue, in which patient population and against which target. When your systems work well, science moves faster and portfolio decision-making gets better.
You will take full operational ownership of shipped models, managing deployment, monitoring, retraining and lifecycle end-to-end. You will make sure that the IT-provisioned experiment tracking and model registry systems are used effectively, that training and fine-tuning runs are consistently and correctly logged and that model artefacts are registered with full provenance from data through to prediction. You will work closely with ML engineers at model handover, reviewing documentation and signing off before accepting operational ownership.
This role is for someone who takes pride in operational excellence and who understands that the AI Accelerator models can only realise their impact on the portfolio if they are deployed and performing reliably in production.
Second round interviews will take place 28th July – 6th August.
This is a hybrid role with approximately 3 days a week in the office.
Boehringer Ingelheim has been recognised as a Top Employer in the UK, demonstrating our commitment to building an exceptional workplace through strong people practices and supportive HR policies.
To learn more about why BI is a great place to work, visit:
https://www.boehringer-ingelheim.co.uk/careers/uk-careers/why-great-place-work

Our people are our strength. And together with over 54,000 colleagues, we're creating the next breakthrough in the world of healthcare and innovation for both humans and animals. Are you ready to join us? #LifeForward
Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice
Imprint: https://www.boehringer-ingelheim.com/imprint